Showing results (81-90 of 308) with videos related to

Sort By:
Pageof 31
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Assessing Cancer Signal during Oral Antiplatelet Therapy in the Food and Drug Administration Adverse Event Reporting System: Mission ImpossibleVictor Serebruany, Moo Hyun Kim, Christian Thevathasan, et al.
International Journal of Cardiology|October 17, 2012
Lost in follow-up rates in TRACER, ATLAS ACS 2, TRITON and TRA 2P trials: challenging PLATO mortality ratesJames J DiNicolantonio, Mehmet Mustafa Can, Victor L Serebruany
Cardiology|October 22, 2015
Should the Dose of Antiplatelet Drugs Be Adjusted for Body Weight? The Example of VorapaxarVictor L Serebruany, Seth D Fortmann, Moo Hyun Kim
The American Journal of Medicine|August 5, 2006
Paradoxical rebound platelet activation after painkillers cessation: missing risk for vascular events?Victor L Serebruany, Alex I Malinin, Deepak L Bhatt
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Mild myocardial stunning affects platelet aggregation and certain hemostatic factors in swineV L Serebruany, V V Yurovsky, P A Gurbel
Pharmacological Research|June 8, 2001
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitorsV L Serebruany, P A Gurbel, C M O'Connor
Thrombosis and Haemostasis|January 25, 2008
Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan)Victor L Serebruany, Alex I Malinin, Dan F Hanley
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 1996
Serial changes of natural antithrombotics during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitorV L Serebruany, W R Herzog, P A Gurbel
American Journal of Therapeutics|May 20, 2009
Eltrombopag (Promacta), a thrombopoietin receptor agonist for the treatment of thrombocytopenia: current and future considerationsVictor L Serebruany, Christian Eisert, Elena Sabaeva, et al.
Expert Review of Cardiovascular Therapy|July 4, 2007
AGI-1067, a novel vascular protectant, anti-inflammatory drug and mild antiplatelet agent for treatment of atherosclerosisVictor L Serebruany, Alex Malinin, Christian Eisert, et al.
Pageof 31